Oxygen Treatment and Pulmonary Arterial Hypertension
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03683082|
Recruitment Status : Unknown
Verified September 2018 by Afroditi Boutou, George Papanicolaou Hospital.
Recruitment status was: Recruiting
First Posted : September 25, 2018
Last Update Posted : September 25, 2018
George Papanicolaou Hospital
Information provided by (Responsible Party):
Afroditi Boutou, George Papanicolaou Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||June 10, 2019|
|Estimated Study Completion Date :||June 30, 2019|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Dipla K, Boutou AK, Markopoulou A, Papadopoulos S, Kritikou S, Pitsiou G, Stanopoulos I, Kioumis I, Zafeiridis A. Differences in cerebral oxygenation during exercise in patients with idiopathic pulmonary fibrosis with and without exertional hypoxemia: does exercise intensity matter? Pulmonology. 2021 Jul 15:S2531-0437(21)00126-4. doi: 10.1016/j.pulmoe.2021.06.006. Online ahead of print.
Boutou AK, Dipla K, Zafeiridis A, Markopoulou A, Papadopoulos S, Kritikou S, Panagiotidou E, Stanopoulos I, Pitsiou G. A randomized placebo-control trial of the acute effects of oxygen supplementation on exercise hemodynamics, autonomic modulation, and brain oxygenation in patients with pulmonary hypertension. Respir Physiol Neurobiol. 2021 Aug;290:103677. doi: 10.1016/j.resp.2021.103677. Epub 2021 May 3.